798 TGFβ blockade in pancreatic cancer enhances sensitivity to combination chemotherapy

• Jennifer Wang,
• Michael Dougan,
• Elisa Bello,
• Marc Pelletier,
• Li Qiang,
• Stephanie Dougan,
• Victoire Cardot-Ruffino,
• Megan Hoffman,
• Lestat Ali,
• Jaime Ivan Castillo Silva,
• Ayantu Temesgen,
• Patrick Lenehan,
• Lauren Kageler,
• Giselle Uribe,
• Annan Yang,
• Andrew J Aguirre,
• Srivatsan Raghavan,
• Viviana Cremasco

Affiliations

Jennifer Wang

2Dana-Farber Cancer Institute, Boston, MA, USA

Michael Dougan

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

Elisa Bello

2Dana-Farber Cancer Institute, Boston, MA, USA

Marc Pelletier

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Li Qiang

1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Stephanie Dougan

2Dana-Farber Cancer Institute, Boston, MA, USA

Victoire Cardot-Ruffino

Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA

Megan Hoffman

2Dana-Farber Cancer Institute, Boston, MA, USA

Lestat Ali

2Dana-Farber Cancer Institute, Boston, MA, USA

Jaime Ivan Castillo Silva

2Dana-Farber Cancer Institute, Boston, MA, USA

Ayantu Temesgen

4Massachusetts General Hospital, Boston, MA, USA

Patrick Lenehan

2Dana-Farber Cancer Institute, Boston, MA, USA

Lauren Kageler

3Harvard Medical School, Boston, MA, USA

Giselle Uribe

2Dana-Farber Cancer Institute, Boston, MA, USA

Annan Yang

2Dana-Farber Cancer Institute, Boston, MA, USA

Andrew J Aguirre

2Dana-Farber Cancer Institute, Boston, MA, USA

Srivatsan Raghavan

2Dana-Farber Cancer Institute, Boston, MA, USA

Viviana Cremasco

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA